相关实验视频

Updated: May 27, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

卵巢癌细胞对IL-15的转呈改善了CD34+原始NK细胞的抗瘤功能

M Vidal-Manrique¹, T Nieuwenstein², L Hooijmaijers¹

¹Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

|February 17, 2025

概括

这项研究表明,用IL-15和IL-15RαmRNA感染卵巢癌细胞可以增强自然杀手 (NK) 细胞疗法. 局部递送促进NK细胞的增殖和抗瘤活性,为卵巢癌治疗提供了更安全的策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

卵巢癌 (OC) 是一种高度致命的妇科恶性瘤.
自然杀手 (NK) 细胞的采用转移是一种有前途的OC疗法,通过IL-15转呈 (transIL-15) 增强.
系统性IL-15模仿剂可能会引起不良影响,而转IL-15对造血原生细胞衍生NK细胞 (HPC-NK) 的疗效尚不清楚.

研究的目的:

研究用IL-15和IL-15RαmRNA感染OC细胞以模仿transIL-15.5的疗效.
评估这种方法对HPC-NK细胞扩张和抗瘤功能的影响in vitro.
探索一种潜在的更安全的方法来增强基于NK细胞的OC免疫疗法.

主要方法:

卵巢癌 (OC) 细胞与IL-15和IL-15RαmRNA共同传染,以实现表面共同表达,模仿转IL-15.
血造原生细胞衍生NK (HPC-NK) 细胞与这些修饰的OC细胞共同培养.
评估了NK细胞的增殖,细胞毒性,细胞因子的产生 (IFNγ) 和大酶B的分泌.

主要成果:

同传染成功地产生了具有表面IL-15和IL-15Rα的转IL-15OC细胞.
与转IL-15 OC 细胞共同培养显著增强了 HPC-NK 细胞增殖,IFNγ 生产,细胞毒性和 B 粒酶分泌.
HPC-NK细胞显示IL-15Rα的吸收,与增强的长期增殖和存活相关,并在OC球体中杀死优异.

结论:

局部传递IL-15和IL-15RαmRNA到OC瘤有效地模仿了transIL-15.
这一策略显著提高了HPC-NK细胞的抗瘤活性和存活率.
向mRNA输送到瘤是一种更安全,更有效的方法,用于增强卵巢癌NK细胞治疗.

关键词:

通过IL-15进行转载.在NK细胞免疫疗法中使用NK细胞免疫治疗.提供mRNA的交付.卵巢癌是发生在卵巢的癌症.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells

Published on: January 15, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...